First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors
PF-06647020(Cofetuzumab Pelidotin)是一种靶向蛋白酪氨酸激酶7的抗体药物偶联物,在晚期实体瘤中的首次人体研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-20-3757
Maitland, Michael L; Sachdev, Jasgit C; Sharma, Manish R; Moreno, Victor; Boni, Valentina; Kummar, Shivaani; Stringer-Reasor, Erica; Lakhani, Nehal; Moreau, Allison R; Xuan, Dawei; Li, Ray; Powell, Eric L; Jackson-Fisher, Amy; Bowers, Michelle; Alekar, Shilpa; Xin, Xiaohua; Tolcher, Anthony W; Calvo, Emiliano